YOU MIGHT BE INTERESTED IN
Anti-Obesity Treatments 2007-2012: A blockbuster target market
By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.
...more details
The World Diabetes Market, 2007-2025: A Key Pharmaceutical Market of the Future
Diabetes affects approximately 246 million people worldwide and this number is increasing. The IDF predict 380 million diabetics by 2025. The Global Diabetes drug treatment market was valued at over $21 billion in 2006 and the market is still expanding rapidly due to the high prevalence of diabetes and lifestyle changes.
...more details
Anti-addiction Therapies, 2006-2011 The Pharmaceutical Industry's Next Viagra?
More money is spent advertising alcohol than any other product. For some, gambling and cigarettes are pleasant distractions, yet for others they are the generators of unbearable cravings and the cause of considerable distress. For them their addition is a disease...
...more details
Cannabinoid Market Forecasts & Analysis to 2012
With 4 drugs now in the marketplace (a 100% rise from 2 years ago), the cannabinoid market continues to grow. Attitudes to the drugs are changing ensuring greater market penetration, and the first cannabinoid blockbuster is now a certainty.
...more details
World market for cancer vaccines 2007-2012
Previously the cancer vaccine market has consisted of HBV (hepatitis B virus) vaccines to prevent liver cancer. 2006 saw the launch of Gardasil the first vaccine against HPV (human papilloma virus) to protect against cervical cancer. Another HPV vaccine, Cervarix, is due to be launched in 2007...
...more details
Tissue Engineering & Stem Cell Technology Report 2007
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.
...more details